Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases
Pin‐Nan Cheng(National Cheng Kung University Hospital), Chun‐Jen Liu(National Taiwan University), Yiheng Li(China University of Geosciences), Wen‐Jone Chen(Min Sheng General Hospital), Chih‐Lin Lin(Chung Shan Medical University Hospital), Wei‐Ting Chang(National Sun Yat-sen University), Jee‐Fu Huang(Kaohsiung Medical University), Charles Jia‐Yin Hou(Mackay Memorial Hospital), Chi-Yi Chen(Chia-Yi Christian Hospital), Jia‐Horng Kao(National Taiwan University Hospital), Cheng‐Yuan Peng(China Medical University), Chung‐Lieh Hung(Mackay Memorial Hospital), Yi‐Hsiang Huang(First Hospital of Lanzhou University), Ming‐Lung Yu(National Sun Yat-sen University), Chun‐Yen Lin(Chang Gung University), Tzung‐Dau Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Chern‐En Chiang(National Yang Ming Chiao Tung University), Chia‐Chi Wang(Taipei Tzu Chi Hospital), Tsung‐Hsien Lin(Kaohsiung Medical University), Yen‐Wen Wu(National Yang Ming Chiao Tung University), Chao‐Yung Wang(National Health Research Institutes), Han‐Chieh Lin(Taipei Veterans General Hospital), Ping‐Yen Liu(National Cheng Kung University Hospital), Ming-Ling Chang(Chang Gung University), Ting‐Hsing Chao(Taipei Veterans General Hospital)
Cited by 20
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Mitotic and G <sub>2</sub> Checkpoint Control: Regulation of 14-3-3 Protein Binding by Phosphorylation of Cdc25C on Serine-216
|Science|1997|1.3k
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension
|New England Journal of Medicine|2021|742
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
|New England Journal of Medicine|2024|693